HIV/AIDS Clinics Sue HHS Over Drug Manufacturers’ Denials of 340B Pricing
(UPDATE Saturday Oct. 10, 2020, 9:20 a.m. EDT—The U.S. Health and Human Services Department (HHS) said
…Category: Breaking
Congressional GOP Committee Leaders Seek 340B Reform Ideas by Oct. 30
The Republican chairman of the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee and the
…A message from 340B Report Publisher and CEO Ted Slafsky: We are pleased to have a sponsored content piece today from Powers Law, based in Washington, D.C. We will have more information about 340B Report sponsorship packages for 2021 in
…Novartis Says It’s Weighing Whether to Start Cutting Off 340B Contract Pharmacy Discounts on Oct. 1. Sanofi Says it Will.
(Update 1, Friday Sept. 25, 1:00 p.m. EDT—Merck is “considering any next steps in our effort to ensure compliance with
…HHS Top Lawyer Tells Lilly, Don’t Assume We Endorse Your 340B Policy
The top lawyer at the U.S. Health and Human Services (HHS) department told drug manufacturer Eli Lilly and Co. in a letter dated Sept. 21 and made
…Rule Implementing 340B Executive Order on Insulin Might be Imminent
The Trump administration signaled today it might publish an interim final rule imminently to implement an executive order requiring community health centers to pass along all 340B savings on insulin
…Breaking News
BREAKING: 22 U.S. Senate Democrats Want Answers from PhRMA About its Members’ 340B Actions
22 U.S. Senate Democrats Want Answers from PhRMA About its Members’ 340B Actions
Twenty-two Democratic U.S. senators asked Pharmaceutical Research and Manufacturers of America (PhRMA) today to inform them by no later than Sept. 29 “regarding steps being taken by
…Breaking News
BREAKING: More than Half of the U.S. House Asks Azar to Address Drug Makers’ 340B Actions Immediately
More than Half of the U.S. House Asks Azar to Address Drug Makers’ 340B Actions Immediately
More than half of the U.S. House today told U.S. Health and Human Services (HHS) Secretary Alex Azar “it is imperative that immediate action
…Breaking News
BREAKING: House Democratic Committee Chairs Say Drug Companies’ Actions Could Put 340B on “Treacherous Path”
House Democratic Committee Chairs Say Drug Companies’ Actions Could Put 340B on “Treacherous Path”
Letting drug manufacturers “pick and choose” which 340B program requirements they will comply with “could set us on a treacherous path where program participants might disregard
…HRSA is Investigating Whether Manufacturer Policies to Restrict 340B Pricing at Contract Pharmacies Violates Statute
In a major development, the Health Resources and Services Administration (HRSA) has told 340B Report that it is investigating whether recent manufacturer policies to restrict
…